Systems and methods for leadless cardiac resynchronization therapy

Patent metadata

Field	Value
Publication number	US-9789319-B2
Application number	US-201414173288-A
Country	US
Kind code	B2
Filing date	Feb 5, 2014
Priority date	Nov 21, 2013
Publication date	Oct 17, 2017
Grant date	Oct 17, 2017

Abstract

Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous device (e.g. subcutaneous implantable (SD)) and a leadless pacing device (LPD) are described. In one or more embodiments, a computer-implemented method includes sensing a first electrical signal from a heart of a patient through a SD. The first signal is stored into memory and serves as a baseline rhythm for a patient. Subsequently, a second signal is sensed from the heart through the SD. A cardiac condition can be detected within the sensed second electrical signal through the SD. A determination is made as to whether cardiac resynchronization therapy (CRT) is appropriate to treat the detected cardiac condition. A determination can then be made as to the timing of pacing pulse delivery to cardiac tissue through a leadless pacing device (LPD). The LPD receives communication from the SD requesting the LPD to deliver CRT to the heart. The SD senses and extracts data from a third electrical signal from the heart of the patient to determine whether the pacing by LPD provided efficacious resynchronization or whether the delivery and timing of the LPD pulse should be modified.

First claim

What is claimed is:

1. A method of using a subcutaneous device (SD) in a patient and a leadless pacing device (LPD) in the patient's heart comprising:
sensing electrical signals from the patient's heart using the SD;
employing the SD to determine whether cardiac resynchronization pacing therapy (CRT pacing) is appropriate based upon the sensed electrical signals;
employing the SD to determine timing of CRT pacing pulses for delivery to cardiac tissue through the LPD and sending signals indicative thereof to the LPD;
responsive to the sent indicative signals, delivering the CRT pacing pulses to the heart using the LPD;
thereafter sensing subsequent electrical signals from the patient's heart using the SD; and
determining, by the SD based on the subsequent electrical signals, whether the CRT pacing by the LPD provided efficacious resynchronization and whether the delivery and timing of subsequent CRT pacing pulses should be modified.

2. The method of claim 1 further comprising:
extracting right ventricular intrinsic activation from the electrical signal through the SD;
determining timing of delivering CRT pacing pulses to a left ventricle from the LPD in response to determining intrinsic conduction data through the SD; and
delivering the CRT pacing pulses to the left ventricle to synchronize with a right ventricle.

3. The method of claim 1 further comprising:
a) extracting electrocardiogram (ECG) data from the electrical signals for an intrinsic rhythm during a conduction test beat;
b) filtering the ECG data with a low pass filter; and
c) detecting fiducial points associated with a QRS wave complex and a P-wave from the ECG data.

4. The method of claim 3 further comprising:
optimizing atrio-ventricular synchrony by delivering LPD pacing at a pre-specified interval after the end of the P-wave.

5. The method of claim 4 wherein the pre-specified interval is one of a fixed number, programmable value, or calculated by the SD from widths of the P-wave and paced QRS complex.

6. The method of claim 4 wherein the pre-specified interval fixed number ranges from about 0 ms to about 60 ms.

7. The method of claim 4 wherein the pre-specified interval fixed number is about 30 ms.

8. The method of claim 3 further comprising:
optimizing the inter-ventricular synchrony by delivering LPD pacing at a pre-specified interval before or after the onset of the QRS complex.

9. The method of claim 8 wherein the pre-specified interval is one of a fixed number, programmable value, or calculated by the SD from widths of the P-wave and paced QRS complex.

10. The method of claim 8 wherein the pre-specified interval fixed number ranges from about 0 to about 60 ms.

11. The method of claim 8 wherein the pre-specified interval fixed number is about 60 ms.

12. The method of claim 1 further comprising:
performing periodic conduction tests and adjusting LPD pacing to maintain atrio-ventricular and inter-ventricular synchrony.

13. A method of using a subcutaneous device (SD) in a patient and a leadless pacing device (LPD) in the patient's heart comprising:
sensing electrical signals from the patient's heart using the SD;
employing the SD to determine whether cardiac resynchronization pacing therapy (CRT pacing) is appropriate based upon the sensed electrical signals;
employing the SD to determine timing of CRT pacing pulses for delivery to cardiac tissue through the LPD and sending signals indicative thereof to the LPD
responsive to the sent indicative signals, delivering the CRT pacing pulses to the heart using the LPD;
thereafter sensing subsequent electrical signals from the patient's heart using the SD;
determining, by the SD based on the subsequent electrical signals, whether the CRT pacing by the LPD provided efficacious resynchronization and whether the delivery and timing of subsequent CRT pacing pulses should be modified; and
analyzing paced QRS morphology from the subsequent electrical signals sensed from the patient's heart acquired by the SD to verify interventricular synchrony.

14. A method of using a subcutaneous device (SD) in a patient and a leadless pacing device (LPD) in the patient's heart comprising:
sensing electrical signals from the patient's heart using the SD;
employing the SD to determine whether cardiac resynchronization pacing therapy (CRT pacing) is appropriate based upon the sensed electrical signals;
employing the SD to determine timing of CRT pacing pulses for delivery to cardiac tissue through the LPD and sending signals indicative thereof to the LPD
responsive to the sent indicative signals, delivering the CRT pacing pulses to the heart using the LPD;
thereafter sensing subsequent electrical signals from the patient's heart using the SD;
determining, by the SD based on the subsequent electrical signals, whether the CRT pacing by the LPD provided efficacious resynchronization and whether the delivery and timing of subsequent CRT pacing pulses should be modified; and
using a Wavelet-like algorithm to determine whether a degree of morphological difference exists between the QRS complex for a signal acquired without pacing and QRS complex for the subsequent electrical signal acquired during pacing.

15. The method of claim 1 further comprising:
ensuring continuous synchronized CRT delivery by the LPD by periodically evaluating intrinsic conduction data monitored through the SD.

16. A method of using a subcutaneous device (SD) in a patient and a leadless pacing device (LPD) in the patient's heart comprising:
sensing electrical signals from the patient's heart using the SD;
employing the SD to determine whether cardiac resynchronization pacing therapy (CRT pacing) is appropriate based upon sensing the electrical signals;
employing the SD to determine timing of CRT pacing pulses for delivery to cardiac tissue through the LPD and sending signals indicative thereof to the LPD
responsive to the sent indicative signals, delivering the CRT pacing pulses to the heart using the LPD;
thereafter sensing subsequent electrical signals from the patient's heart using the SD;
determining, by the SD based on the subsequent electrical signals, whether the CRT pacing by the LPD provided efficacious resynchronization and whether the delivery and timing of subsequent CRT pacing pulses should be modified; and
sensing electrical signals from a substernally placed lead extending from the SD.

17. A method comprising:
sensing a first electrical signal by a subcutaneous implanted device (SD) from a heart of a patient;
detecting a cardiac condition within the sensed first electrical signal;

determining, by the SD and based on the detected cardiac condition, timing of delivery of cardiac resynchronization therapy (CRT) to the patient to treat the detected cardiac condition;
receiving, by a leadless pacing device (LPD) implanted within the heart of the patient, communication from the SD requesting the LPD deliver CRT to the heart;
sensing, by the LPD, a second electrical signal from the heart of the patient; and
determining, by the LPD and based on the second electrical signal, whether to deliver pacing to the heart from the LPD and whether timing of the pacing should be adjusted to provide more efficient resynchronization.

18. The method of claim 17 , wherein determining how to deliver CRT to the heart from the LPD comprises detecting, by the SD, a cardiac condition eligible for CRT.

19. The method of claim 17 , wherein the method further comprises:
in response to detecting the cardiac condition elig

Assignees

• Medtronic Inc

Inventors

• Sambelashvili Aleksandre T

Classifications

• A61N1/3684

  for stimulating the heart at multiple sites of the ventricle or the atrium · CPC title

• A61N1/3682 Primary

  with a variable atrioventricular delay · CPC title

• A61N1/3688

  configured for switching the pacing mode, e.g. from AAI to DDD · CPC title

• A61N1/36592

  controlled by the heart rate variability · CPC title

• A61N1/36842

  Multi-site stimulation in the same chamber · CPC title